Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)

Disposition of Δ9tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoprotein

(2008) Laurence Bonhomme-Faivre et al.   ADDICTION BIOLOGY

pH dependent efflux of methamphetamine derivatives and their reversal through human Caco-2 cell monolayers

(2008) Andrew Crowe et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence

(2008) Orna Levran et al.   HUMAN MOLECULAR GENETICS

ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier

(2008) Sandrine Dauchy et al.   JOURNAL OF NEUROCHEMISTRY

The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids

(2007) M L Holland et al.   BRITISH JOURNAL OF PHARMACOLOGY

No Influence of ABCB1 Haplotypes on Methadone Dosage Requirement

(2007) S Crettol et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein

(2007) Hao-Jie Zhu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY